<DOC>
	<DOCNO>NCT00069082</DOCNO>
	<brief_summary>This 49-day study evaluate effectiveness Intranasal Civamide ( Zucapsaicin ) treatment episodic cluster headache period compare placebo ( medically inactive substance contain active ingredient ) .</brief_summary>
	<brief_title>Intranasal Civamide Episodic Cluster Headache</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Cluster Headache</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>At least 2 year history episodic cluster headache ( meet IHS criterion ) At least 2 previous episode Expected duration cluster period least 6 week longer 24 week At least 1 8 headache 3 day immediately prior treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Headache</keyword>
	<keyword>Cluster</keyword>
	<keyword>EC</keyword>
	<keyword>Episodic Cluster</keyword>
</DOC>